Nothing does it for TheraRead the posters and they are very good and summarize very well the state of the Th1902 program and its clinical effects. Still nobody wants to buy the stock. Long term rock solid investors are selling out of total disgust because nothing good ever happens to their investment since this management and BOD took the elm. They stole it with the last deal actually.